AIM leadership team

AIM leadership team

Our leadership team leverages its expertise from decades of health care experience to develop transformative solutions and strategies that benefit health plans, providers, and consumers.

President

Robert Mandel, MD, MBA

Robert Mandel, President, oversees the strategic direction of AIM Specialty Health, ensuring that the care delivered to health plan members is appropriate, safe, and affordable.

Chief Medical Officer

Femi Adewunmi, MD, MBA

Femi Adewunmi is the Chief Medical Officer at AIM. He drives improved quality, integrity, and performance of AIM solutions, leads the AIM team of solution medical directors, and collaborates with clients to achieve better health outcomes while improving costs.

Senior Vice President, Clinical Programs

Julie Thiel, MD

Julie Thiel, MD is the Senior Vice President of Clinical Operations for AIM. As a member of the executive team, she oversees the AIM clinical review process and operational workflows that help ensure care that aligns with medical evidence.

Vice President and Medical Director, Oncology

Stacey Ban, MD

Stacey Ban, MD, serves as the Vice President and Medical Director for the AIM Medical Oncology Solution. She provides front line clinical expertise including the development of AIM Cancer Treatment Pathways. She played an important role leading the clinical process during the implementation of our solutions for Medical Oncology and Radiation Therapy.

Associate Chief Medical Officer and National Medical Director, Radiology and Guideline Development

Chris Buckle, MD, MBA, FRCPC

Chris Buckle, MD, is our associate chief medical officer and also serves as the clinical lead for radiology at AIM. In his role, Dr. Buckle is responsible for defining the clinical strategy of our flagship solution.

National Medical Director, Medical Oncology Programs and Genetics

Michael J. Fisch, MD, MPH, FACP, FAAHPM, FASCO

Michael Fisch, MD, serves as National Medical Director of Medical Oncology Programs and Genetics for AIM. In his role, he works closely with the executive leadership team to provide clinical expertise for the expansion of the AIM Medical Oncology Solution and for the AIM Genetic Testing Solution.

Rupa I. Nimmagadda, MD

Associate Medical Director, Government Programs

Rupa I. Nimmagadda, MD, MA

Rupa I. Nimmagadda, MD, MA, serves as Associate Medical Director of Government Programs. Her focus is on providing guidance to ensure that AIM solutions meet government program mandates and requirements for the Medicaid line of business.

Matt Patton

Associate Medical Director, Surgical Procedures Solution

Matthew S. Patton, MD

Matthew S. Patton, MD, is Associate Medical Director of the Surgical Procedures Solution at AIM. He provides operational leadership to ensure the solution is both clinically accurate and responsive, based on real-time provider engagement data.

National Medical Director, Cardiology, Sleep Medicine, and Surgical Procedures

Thomas P. Power, MD, FACC, MRCPI, MBA

Thomas Power, MD, is the National Medical Director of Cardiology, Sleep Medicine, and Surgical Procedures for AIM. Dr. Power is responsible for the clinical components of the Cardiology, Sleep, and Surgical Procedures Solutions.

National Medical Director, Rehabilitation and Back Pain Management

Kerrie Reed, MD

As the National Medical Director for the AIM Rehabilitation and Back Pain Management Solutions, Kerrie Reed, MD, is responsible for developing clinical strategy, enhancing provider engagement, and developing growth initiatives.

National Medical Director, Musculoskeletal

Richard Valdesuso, MD, MBA, MA

Richard Valdesuso, MD, serves as the National Medical Director of the Musculoskeletal Solution for AIM. In his role, he is responsible for defining the clinical strategy of the solution.

National Medical Director, Radiation Oncology

Robert P. Zimmerman, MD

Robert Zimmerman, MD, serves as National Medical Director of Radiation Oncology at AIM. In his role, he provides clinical leadership and guides the development of AIM Guidelines to ensure consistent use of appropriate radiation within our Oncology Solution.

See what our customers have to say